Retrospective Safety Survey in patients included in phase I-II NV1FGF clinical trials. (TALISMAN SURVEY)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/07/2010 - 31/12/2010
Description
The objective of this study is to collect retrospectively long term safety data in patients who have participated in the previous phase I-II trials conducted with the compound.
Keywords: PAVK; Gentherapie
Funding identifier: XRP0038/NV1FGF
Funder / funding scheme:
- Sanofi-Aventis Groupe S.A. (France)
Project management at the University of Münster
| Reinecke, Holger |
Applicants from the University of Münster
| Reinecke, Holger |